STAT+: The FDA’s ‘breakthrough’ program for medical devices keeps gaining steam
For medical devices in the Breakthrough Devices Program, 2022 has been a breakout year.
The Food and Drug Administration is on track to top its previous records, offering expedited regulatory consideration — and if medical device companies have their way, a streamlined path to insurance coverage — to dozens of novel tools.
Continue to STAT+ to read the full story…
